PAQ®, A SIMPLE 3-DAY BASAL/BOLUS INSULIN DELIVERY DEVICE, FOR PEOPLE WITH TYPE 2 DIABETES

被引：0
|
作者：
Mader, J. K. [1 ]
Lilly, L. C. [2 ]
Aberer, F. [1 ]
Poettler, T. [1 ]
Becvar, S. [1 ]
Lanz, C. [1 ]
Trautmann, M. [2 ]
Pieber, T. R. [1 ]
机构：
[1] Med Univ Graz, Endocrinol & Metab, Graz, Austria
[2] CeQur Corp, Clin Res, Marlborough, MA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
270
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [1] PaQ®, a simple 3-day basal/bolus insulin delivery device, in people with type 2 diabetes
    Mader, J. K.
    Lilly, L. C.
    Aberer, F.
    Pachatz, J.
    Korsatko, S.
    Damsbo, P.
    Pieber, T. R.
    BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK, 2013, 58
  • [2] PAQ, A SIMPLE 3-DAY BASAL/BOLUS INSULIN DELIVERY DEVICE, IN PATIENTS WITH TYPE 2 DIABETES
    Mader, J. K.
    Lilly, L. C.
    Aberer, F.
    Pachatz, J.
    Korsatko, S.
    Damsbo, P.
    Pieber, T. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A14 - A14
  • [3] A Feasibility Assessment of PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, in Patients With Type 2 Diabetes
    Mader, Julia K.
    Lilly, Leslie C.
    Aberer, Felix
    Pachatz, Joerg
    Korsatko, Stefan
    Strock, Ellie
    Mazze, Roger
    Damsbo, Peter
    Pieber, Thomas R.
    DIABETES, 2013, 62 : A253 - A253
  • [4] A feasibility assessment of PaQ®, a simple 3-day basal/bolus insulin delivery device, in patients with type 2 diabetes
    Mader, J. K.
    Lilly, L. C.
    Aberer, F.
    Kojzar, H.
    Korsatko, S.
    Strock, E.
    Mazze, R.
    Damsbo, P.
    Pieber, T. R.
    DIABETOLOGIA, 2013, 56 : S445 - S446
  • [5] Use of PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, Reduces Barriers to Insulin Therapy in Patients With Type 2 Diabetes
    Hermanns, Norbert
    Lilly, Leslie
    Mader, Julia K.
    Aberer, Felix
    Pachatz, Joerg
    Korsatko, Stefan
    Warner, Jay
    Pieber, Thomas
    DIABETES, 2013, 62 : A205 - A205
  • [6] PaQ®, a simple 3-day basal/bolus insulin delivery device, may optimise insulin delivery in type 2 diabetes as determined by continuous glucose monitoring
    Mazze, R.
    Strock, E.
    Mader, J.
    Lilly, L.
    Aberer, F.
    Pieber, T.
    DIABETOLOGIA, 2014, 57 : S413 - S413
  • [7] A Study to Assess the Performance of PaQ®, a Simple 3-Day Basal Bolus Insulin Delivery Device, after 12 Weeks of Treatment in People with Type 2 Diabetes
    Mader, Julia K.
    Lilly, Leslie C.
    Aberer, Felix
    Poettler, Tina
    Trautmann, Michael
    Pieber, Thomas R.
    DIABETES, 2015, 64 : A272 - A272
  • [8] PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, May Optimize Insulin Delivery in Type 2 Diabetes as Determined by Continuous Glucose Monitoring
    Strock, Ellie
    Mader, Julia K.
    Lilly, Leslie C.
    Aberer, Felix
    Pieber, Thomas R.
    Mazze, Roger
    DIABETES, 2014, 63 : A602 - A602
  • [9] USE OF PAQ®, A SIMPLE 3-DAY BASAL/BOLUS INSULIN DELIVERING DEVICE, REDUCES BARRIERS TO INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES
    Hermanns, N.
    Lilly, L. C.
    Mader, J. K.
    Aberer, F.
    Pachatz, J.
    Korsatko, S.
    Warner, J.
    Pieber, T. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A19 - A19
  • [10] A Feasibility Study of a 3-Day Basal- Bolus Insulin Delivery Device in Individuals With Type 2 Diabetes
    Mader, Julia K.
    Lilly, Leslie C.
    Aberer, Felix
    Korsatko, Stefan
    Strock, Ellie
    Mazze, Roger S.
    Damsbo, Peter
    Pieber, Thomas R.
    DIABETES CARE, 2014, 37 (05) : 1476 - 1479
12345